In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer. In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.
More strictly designed clinical trial studies are needed to replicate this finding."
Kai Wang, PhD., first author from Harvard University
Source:
Journal reference:
Wang, K., et al. (2019) Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine. doi.org/10.1002/cam4.2500.